J&J says it will be able to provide 20 million US doses of its COVID-19 vaccine by end of March

Drugmaker Johnson & Johnson says it will be able to provide 20 million U.S. doses of its single-shot COVID-19 vaccine by the end of March, assuming it gets the greenlight from federal regulators.

More Stories

Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19

01:25

Pharmacies say they have not received orders for newest COVID booster

00:21

Biden administration announces $600M to produce COVID tests and will reopen website to order them

00:41

Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days

02:13

NYSDOH: COVID numbers up with new variant accounting for 17% of new cases

02:30

NYSHD: Hospitalizations caused by COVID increase by 22% in a week